Skip to content

Remina- Evaluation of a digital aftercare program for psychosomatic rehabilitation

Remina- Evaluation of a digital aftercare program for psychosomatic rehabilitation - Remina

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00039279
Enrollment
588
Registered
2026-02-19
Start date
2026-02-17
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychosomatic rehabilitation patients with depressive disorders (F32.x, F33.x [außer F32.3, F33.3], F34.1, F31.3), neurotic, stress-related, and/or somatoform disorders (F40.x, F41.0, F41.1, F41.2, F41.3, F41.8, F41.9, F43.2, F45.0, F48.0) as the main or secondary diagnosis

Interventions

Group 1: Intervention group: 6-month digital psychosomatic aftercare program 'Rethera Mind' (individual digital admission and offboarding session (50 minutes each), 25 weekly digital group sessions (6

Sponsors

MEDIAN Unternehmensgruppe B.V. & Co. KG
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients: - Completed inpatient or outpatient rehabilitation within the past = 12 weeks - Diagnosis of a depressive disorder (F32.x, F33.x [excluding F32.3, F33.3], F34.1, F31.3) and/or a neurotic, stress-related, or somatoform disorder (F40.x, F41.0, F41.1, F41.2, F41.3, F41.8, F41.9, F43.2, F45.0, F48.0) as the main or secondary diagnosis Staff - Therapeutic or administrative role in the preparation or delivery of the digital aftercare program Rethera Mind - Direct contact with patients in daily work - Use of the digital application(s) for the aftercare with Rethera Mind as part of daily work routines

Exclusion criteria

Exclusion criteria: Patients: - Acute suicidality or a recent suicide attempt - Acute severe psychiatric disorder - Substance use disorder with lack of abstinence Applicable only to digital aftercare with Rethera Mind or conventional aftercare with Psy-RENA: - Insufficient treatment adherence and/or insufficient treatment motivation Applicable only to digital aftercare with Rethera Mind: - Pathological internet or computer use - Cognitive or motor impairments that prevent use of the app - Lack of required technical resources (e.g., suitable device, internet access) or insufficient digital literacy

Design outcomes

Primary

MeasureTime frame
- Psychological and somatic symptoms of the patient, assessed using the 'psychological and somatic symptoms' (PSB) module of the Hamburg Modules for the Assessment of Psychosocial Health in Clinical Practice (HEALTH-49) at the end of rehabilitation / start of aftercare and at the 6-month follow-up / end of aftercare - Subjective work ability of the patient, assessed using the Work Ability Score (WAS) of the Work Ability Index (WAI) at the end of rehabilitation / start of aftercare and at the 6-month follow-up / end of aftercare

Secondary

MeasureTime frame
- Additional aspects of psychosocial health, assessed using the remaining subscales of the HEALTH-49 questionnaire (psychological wellbeing, interactional difficulties, self-efficacy, activity and participation, social support / social burden) at the end of rehabilitation / start of aftercare and at the 6-month follow-up / end of aftercare - Symptom severity (indication specific): depressive symptoms, assessed using the Patient Health Questionnaire-9 (PHQ-9), generalized anxiety symptoms using the Generalized Anxiety Disorder Scale-7 (GAD-7), somatic symptoms, using the Patient Health Questionnaire-15 (PHQ-15) at the end of rehabilitation / start of aftercare and at the 6-month follow-up / end of aftercare - Feasibility parameters: drop-out-rate, adherence to group sessions, adherence to app use (intervention group only), acceptance of the aftercare among participants and staff (self-developed items), and aftercare services delivered as part of the Rethera Mind program (intervention group only)

Countries

Germany

Contacts

Public ContactJudith Dittmer

MEDIAN Unternehmensgruppe B.V. & Co. KG

judith.dittmer@median-kliniken.de+49 30 530055 261

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026